Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
China
· Delayed Price · Currency is CNY 12.77
-0.25 (-1.92%)
Jun 18, 2025, 2:45 PM CST
Shanghai No.1 Pharmacy Revenue
Shanghai No.1 Pharmacy had revenue of 503.96M CNY in the quarter ending March 31, 2025, with 9.07% growth. This brings the company's revenue in the last twelve months to 1.96B, up 7.38% year-over-year. In the year 2024, Shanghai No.1 Pharmacy had annual revenue of 1.92B with 5.26% growth.
Revenue (ttm)
1.96B
Revenue Growth
+7.38%
P/S Ratio
1.48
Revenue / Employee
2.29M
Employees
856
Market Cap
2.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.92B | 95.64M | 5.26% |
| Dec 31, 2023 | 1.82B | -836.39M | -31.49% |
| Dec 31, 2022 | 2.66B | 1.26B | 89.94% |
| Dec 31, 2021 | 1.40B | -188.62M | -11.89% |
| Dec 31, 2020 | 1.59B | 343.73M | 27.65% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |